BCRI - Brazilian Clinical Research Institute
BCRI is the first Academic Research Organization in Latin America, founded in São Paulo in 2008 as a non-profit. It delivers end-to-end clinical research services—protocol development, site management, regulatory affairs, pharmacovigilance, and biostatistics—to pharmaceutical and biotech sponsors across Brazil and Latin America.
- Company typePrivate
- Founded2008
- HeadquartersSão Paulo, Brazil
- Headcount51–100
- GTM typeB2B
- OfferingServices
What BCRI - Brazilian Clinical Research Institute does
BCRI - Brazilian Clinical Research Institute is a non-profit Academic Research Organization (ARO) headquartered in São Paulo, Brazil, founded in 2008 by Prof. Dr. Renato D. Lopes as the first ARO created in Latin America. The organization was established as the regional ARO partner of the Duke Clinical Research Institute (DCRI), the world's largest Academic Research Organization, and today operates embedded within the TribeMD Group ecosystem of independent medical education and teaching companies. Its mission is to formalize scientific and operational expertise in clinical research across Latin America, working in close collaboration with leading academic and private hospitals in the region.
BCRI delivers a comprehensive, end-to-end suite of clinical research services spanning protocol conception through results dissemination. Core offerings include academic leadership, clinical research protocol development, project management, site feasibility and selection, regulatory affairs, site management and monitoring, supply chain management, pharmacovigilance and Clinical Event Classification (CEC) services, contracts and payments, pricing and proposals, and statistical analysis and data management. Education and training programs for investigators and coordinators are delivered in partnership with TribeMD Academy. The organization also operates two digital platforms—a Research Center Registration Platform (bcri.org.br/cadastro) and a CV Registration Platform (bcri.org.br/cadastro-cv)—that lower the friction of site and talent sourcing across Latin America. All operations adhere to ICH-GCP and local regulatory standards.
BCRI's business model is based on research funding contracts, NIH-sponsored studies, and partnerships with pharmaceutical and biotech companies—classified as a professional services revenue stream rather than a commercial product model. The organization has conducted more than 60 clinical studies, enrolled over 80,000 patients, produced over 800 scientific publications (approximately 30% in The Lancet, JAMA, New England Journal of Medicine, and Circulation), and serves both human health sponsors (NIH, DCRI, academic and private hospitals) as its primary constituents. Customer segments span pharmaceutical and biotech sponsors, research centers and hospitals, and healthcare professionals (investigators and coordinators).
BCRI - Brazilian Clinical Research Institute firmographics
Firmographics- Name
- BCRI - Brazilian Clinical Research Institute
- Legal name
- Brazilian Clinical Research Institute
- Website
- https://bcri.org.br
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BCRI is the first Academic Research Organization in Latin America, founded in São Paulo in 2008 as a non-profit. It delivers end-to-end clinical research services—protocol development, site management, regulatory affairs, pharmacovigilance, and biostatistics—to pharmaceutical and biotech sponsors across Brazil and Latin America.
- Ownership category
- akta.pro rank
BCRI - Brazilian Clinical Research Institute industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Clinical CROs (Phase I–IV)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)
Keywords
Where BCRI - Brazilian Clinical Research Institute is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
BCRI - Brazilian Clinical Research Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Non-profit Research Funding: As a non-profit academic research organization, BCRI operates through research grants, NIH-sponsored studies, and partnerships with pharmaceutical companies for clinical trial execution. Revenue is generated through research funding contracts rather than commercial product sales.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
BCRI - Brazilian Clinical Research Institute product offering
Product offeringCore offering
BCRI is a non-profit Academic Research Organization (ARO) that provides comprehensive clinical research services spanning all phases—from protocol development and project management through regulatory affairs, site monitoring, pharmacovigilance, and data analysis. The organization conducts international multicenter clinical studies across Latin America, including NIH-sponsored research, leveraging its partnership with the Duke Clinical Research Institute (DCRI) and embedded position in the TribeMD Group ecosystem.
Product overview
BCRI (Brazilian Clinical Research Institute) is an Academic Research Organization (ARO) offering a comprehensive suite of clinical research services and platforms. The core offering consists of clinical research services spanning all phases—from protocol development through execution to results—featuring academic leadership, project management, regulatory affairs, site monitoring, pharmacovigilance, and data analysis. BCRI also operates complementary platforms: a Research Center Registration Platform for onboarding new research sites, and a CV Registration Platform for recruiting clinical research professionals. Education programs are delivered through partnership with TribeMD Academy. The organization tracks specific clinical studies (Ischemia, Appraise-2) as named product offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Comprehensive Clinical Research Services
- Clinical Event Classification (CEC) Services
- Regulatory Affairs Services
- Clinical Research Education Programs
- Research Center Registration Platform
- Research Center Management and Monitoring
- Biostatistics and Data Management
Quantifiable outcome
- 80,000+ patients enrolled in clinical studies
- +2 more outcomes
Companies that use BCRI - Brazilian Clinical Research Institute
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
BCRI - Brazilian Clinical Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
BCRI - Brazilian Clinical Research Institute partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Duke Clinical Research Institute (DCRI)coreBCRI was founded as an ARO partner of the Duke Clinical Research Institute (DCRI) in Latin America. DCRI is the world's largest Academic Research Organization. This partnership provides BCRI with access to DCRI's methodology, training, and international research standards, establishing credibility and technical expertise.
- TribeMD GroupcoreBCRI is embedded in an ecosystem of independent medical education and teaching companies, the TribeMD Group. This includes TribeMD Academy for clinical research education programs and TribeMD for medical education content. The ecosystem provides educational infrastructure and cross-promotional opportunities.
- Research Center Network (Latin America)coreBCRI works in close collaboration with leading academic and private hospitals across Latin America. These partnerships enable the organization to conduct clinical studies across a vast geographic area, with each center representing a site of excellence for clinical research execution.
Scale indicators6 records
Recent moves7 records
Expansion highlights4 records
BCRI - Brazilian Clinical Research Institute competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Full-service biopharmaceutical solutions organization with clinical research capabilities across Latin America, offering comparable end-to-end CRO services to BCRI.
- IQVIA: The world's largest CRO with extensive Latin American operations. Competes with BCRI for multicenter clinical trial execution but operates a vastly broader portfolio across all therapeutic areas and geographies.
- Medpace: Mid-to-large global CRO with growing Latin American presence, particularly strong in cardiovascular and metabolic trials — directly overlapping BCRI's therapeutic focus.
- Charles River Laboratories: Global CRO with early-stage clinical services and broader life sciences capabilities, competing for sponsor relationships that could otherwise go to regional AROs like BCRI.
- Parexel: Major global CRO with established site networks in Latin America, competing for the same pharma-sponsored multicenter studies BCRI targets.
- ICON plc: Global CRO with significant operations across Latin America and full-service clinical research capabilities directly overlapping BCRI's end-to-end service offering.
Others
- TribeMD Group: The medical education and teaching company ecosystem that BCRI is embedded within. While not a direct competitor, TribeMD shares management overlap and provides BCRI's investigator training infrastructure.
Direct peers
- Duke Clinical Research Institute (DCRI): BCRI was founded as the Latin American ARO partner of DCRI, the world's largest academic research organization. They share the ARO model, scientific governance approach, and BCRI leverages DCRI's methodology and CEC expertise.
Regional players
- Hospital Israelita Albert Einstein: Leading Brazilian hospital that conducts clinical research through its own research institute and could serve as both a partner site and potential competitive research operator within BCRI's home market.
- Hospital de Clínicas de Porto Alegre: Major Brazilian academic hospital with clinical research capabilities that may partner with or compete against BCRI for multicenter study execution in southern Brazil.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BCRI - Brazilian Clinical Research Institute social profiles
Digital presenceBCRI - Brazilian Clinical Research Institute compliance and trust
Trust signalCompliance1 record
BCRI - Brazilian Clinical Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
BCRI - Brazilian Clinical Research Institute leadership team
Management profileNumber of profiles
Profiles9 records
BCRI - Brazilian Clinical Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BCRI - Brazilian Clinical Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BCRI - Brazilian Clinical Research Institute
What does BCRI - Brazilian Clinical Research Institute do?
BCRI is a non-profit Academic Research Organization (ARO) that provides comprehensive clinical research services spanning all phases—from protocol development and project management through regulatory affairs, site monitoring, pharmacovigilance, and data analysis. The organization conducts international multicenter clinical studies across Latin America, including NIH-sponsored research, leveraging its partnership with the Duke Clinical Research Institute (DCRI) and embedded position in the TribeMD Group ecosystem.
Is BCRI - Brazilian Clinical Research Institute a public or private company?
BCRI - Brazilian Clinical Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was BCRI - Brazilian Clinical Research Institute founded?
BCRI - Brazilian Clinical Research Institute was founded in 2008. It employs 51 to 100 people.
Where is BCRI - Brazilian Clinical Research Institute based?
BCRI - Brazilian Clinical Research Institute is headquartered in São Paulo, Brazil, in the Latin America region.
How does BCRI - Brazilian Clinical Research Institute make money?
One revenue line is on record: non-profit Research Funding.
Who are BCRI - Brazilian Clinical Research Institute's main competitors?
Broad incumbents on record are Syneos Health, IQVIA, Medpace, Charles River Laboratories, Parexel and ICON plc. TribeMD Group is listed as an others. Duke Clinical Research Institute (DCRI) is listed as a direct peer. Regional players are Hospital Israelita Albert Einstein and Hospital de Clínicas de Porto Alegre.
Does BCRI - Brazilian Clinical Research Institute have an API?
No public API is recorded for BCRI - Brazilian Clinical Research Institute.
What industry is BCRI - Brazilian Clinical Research Institute in?
BCRI - Brazilian Clinical Research Institute's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.